Witnesses press Medicare coverage for pharmacist "test-and-treat" services to preserve rural access

Ways and Means: House Committee · November 20, 2025

Get AI-powered insights, summaries, and transcripts

Subscribe
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

Community pharmacists told the House subcommittee they are frequent access points in rural areas and urged Congress to enact HR 3164 (ECAPS) to let Medicare reimburse pharmacist services such as testing and treating certain conditions to reduce ER use and stabilize local pharmacies.

WASHINGTON — Community pharmacists and lawmakers told a House Ways and Means subcommittee that expanding Medicare coverage for pharmacist-provided services could keep care local, reduce emergency visits and stabilize independent pharmacies in rural areas.

Lisonbee Reichert, a pharmacist and vice president of operations at Bodie Drug, described community pharmacies as "the front door to the health-care system" in rural Illinois and said pharmacists perform screenings, immunizations and chronic-disease monitoring. She told the panel that "community pharmacists represent a currently underutilized health-care resource" and urged support for HR 3164, the Ensuring Community Access to Pharmacist Services Act (ECAPS), which would allow Medicare reimbursement for certain pharmacist-provided testing and treatment.

Reichert said pharmacies often communicate with physicians by phone and that "enhanced interoperability" would improve coordination with primary-care providers. Members pressing for rural access noted pharmacy closures in 2024 and asked how ECAPS could help preserve local capacity; Reichert replied that reimbursing pharmacist services would shift care from distant emergency departments back into community settings and help sustain local businesses.

Committee members underscored that community pharmacists frequently act as first-line clinicians when primary care is scarce. Reichert recounted typical pharmacist activities: monitoring blood pressures, reviewing lab values, identifying adverse drug events, and counseling patients. The panel did not vote on ECAPS; members encouraged further review and indicated interest in legislation that would enable pharmacists to practice "at the top of their license."